Shane Climie

1.7k total citations
18 papers, 568 citations indexed

About

Shane Climie is a scholar working on Molecular Biology, Infectious Diseases and Materials Chemistry. According to data from OpenAlex, Shane Climie has authored 18 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Materials Chemistry. Recurrent topics in Shane Climie's work include Biochemical and Molecular Research (7 papers), RNA and protein synthesis mechanisms (4 papers) and Enzyme Structure and Function (4 papers). Shane Climie is often cited by papers focused on Biochemical and Molecular Research (7 papers), RNA and protein synthesis mechanisms (4 papers) and Enzyme Structure and Function (4 papers). Shane Climie collaborates with scholars based in Canada, United States and United Kingdom. Shane Climie's co-authors include James D. Friesen, Daniel V. Santi, Martin Sumner-Smith, S De Grandis, James Brunton, Richard W. Barnett, Lorne S. Reid, Christopher W. Carreras, Ulrike Delling and Nahum Sonenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Shane Climie

18 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shane Climie Canada	12	422	110	103	102	74	18	568
Sebastian Rämisch Sweden	11	303 0.7×	56 0.5×	39 0.4×	55 0.5×	24 0.3×	14	474
Rosario Sabariegos Spain	11	358 0.8×	23 0.2×	54 0.5×	28 0.3×	158 2.1×	19	534
A. Goepfert Switzerland	10	239 0.6×	37 0.3×	41 0.4×	105 1.0×	106 1.4×	16	568
Daying Wen Australia	13	290 0.7×	28 0.3×	274 2.7×	34 0.3×	54 0.7×	16	865
Philippe J. Mas France	14	576 1.4×	46 0.4×	73 0.7×	14 0.1×	75 1.0×	20	836
Feroza Ardeshir United States	15	540 1.3×	79 0.7×	38 0.4×	29 0.3×	276 3.7×	18	821
Kenneth R. Maksimchuk United States	7	615 1.5×	21 0.2×	103 1.0×	19 0.2×	128 1.7×	10	762
Dorothea Sizmann Switzerland	13	391 0.9×	69 0.6×	159 1.5×	8 0.1×	72 1.0×	15	736
Charles Zhu United States	11	241 0.6×	18 0.2×	28 0.3×	32 0.3×	63 0.9×	13	508
Lawrence T. Malek Canada	15	294 0.7×	19 0.2×	91 0.9×	11 0.1×	61 0.8×	20	547

Countries citing papers authored by Shane Climie

Since Specialization

Citations

This map shows the geographic impact of Shane Climie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Climie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Climie more than expected).

Fields of papers citing papers by Shane Climie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane Climie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Climie. The network helps show where Shane Climie may publish in the future.

Co-authorship network of co-authors of Shane Climie

This figure shows the co-authorship network connecting the top 25 collaborators of Shane Climie. A scholar is included among the top collaborators of Shane Climie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane Climie. Shane Climie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Dove, Peter, Shane Climie, Zezhou Wang, et al.. (2015). FV-009 candidate drug: Novel and selective P/Q-type Ca2+ and voltage-gated Na+ ion channel modulation for epilepsy and pain. Epilepsy & Behavior. 46. 57–57. 1 indexed citations

Dove, Peter, Aisha Shamas‐Din, Alex Nachman, et al.. (2015). FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing. Cell Death and Disease. 6(7). e1815–e1815. 2 indexed citations

Dove, Peter, Shane Climie, Zezhou Wang, et al.. (2015). FV-082: A safer orally active broad-spectrum antiepileptic drug candidate. Epilepsy & Behavior. 46. 57–58. 1 indexed citations

Toledo‐Sherman, Leticia, Leroi V. DeSouza, Christopher M. Hosfield, et al.. (2004). New targets for an old drug. Clinical Proteomics. 1(1). 45–67. 10 indexed citations

Climie, Shane, et al.. (1999). Functional assessment of surface loops: deletion of eukaryote-specific peptide inserts in thymidylate synthase of Saccharomyces cerevisiae. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1430(1). 1–13. 2 indexed citations

Payette, Paul, et al.. (1997). Development of an enzyme-linked immunosorbent assay for measurement of serum-associated ALX40-4C. Clinical and Diagnostic Laboratory Immunology. 4(6). 671–675. 1 indexed citations

Sumner-Smith, Martin, et al.. (1995). Antiherpetic activities of N-alpha-acetyl-nona-D-arginine amide acetate.. PubMed. 21(1). 1–6. 25 indexed citations

Climie, Shane, et al.. (1994). Expression of Trimeric Human dUTP Pyrophosphatase in Escherichia coli and Purification of the Enzyme. Protein Expression and Purification. 5(3). 252–258. 25 indexed citations

Reid, Lorne S., et al.. (1993). Design and synthesis of RNA miniduplexes via a synthetic linker approach. Biochemistry. 32(7). 1751–1758. 36 indexed citations

10.

McCallum, Kirk, et al.. (1993). Design and synthesis of RNA miniduplexes via a synthetic linker approach. 2. Generation of covalently closed, double-stranded cyclic HIV-1 TAR RNA analogs with high Tat-binding affinity. Nucleic Acids Research. 21(11). 2585–2589. 28 indexed citations

11.

Carreras, Christopher W., Shane Climie, & Daniel V. Santi. (1992). Thymidylate synthase with a C-terminal deletion catalyzes partial reactions but is unable to catalyze thymidylate formation. Biochemistry. 31(26). 6038–6044. 20 indexed citations

12.

Climie, Shane, Christopher W. Carreras, & Daniel V. Santi. (1992). Complete replacement set of amino acids at the C-terminus of thymidylate synthase: quantitative structure-activity relationship of mutants of an enzyme. Biochemistry. 31(26). 6032–6038. 27 indexed citations

13.

Delling, Ulrike, Lorne S. Reid, Richard W. Barnett, et al.. (1992). Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure. Journal of Virology. 66(5). 3018–3025. 75 indexed citations

14.

Climie, Shane, Luis M. Ruiz‐Pérez, Dolores González‐Pacanowska, et al.. (1990). Saturation site-directed mutagenesis of thymidylate synthase.. Journal of Biological Chemistry. 265(31). 18776–18779. 80 indexed citations

15.

Climie, Shane & Daniel V. Santi. (1990). Chemical synthesis of the thymidylate synthase gene.. Proceedings of the National Academy of Sciences. 87(2). 633–637. 41 indexed citations

16.

Climie, Shane & James D. Friesen. (1988). In vivo and in vitro structural analysis of the rplJ mRNA leader of Escherichia coli. Protection by bound L10-L7/L12.. Journal of Biological Chemistry. 263(29). 15166–15175. 38 indexed citations

17.

Climie, Shane & James D. Friesen. (1987). Feedback regulation of the rplJL-rpoBC ribosomal protein operon of Escherichia coli requires a region of mRNA secondary structure. Journal of Molecular Biology. 198(3). 371–381. 39 indexed citations

18.

Grandis, S De, et al.. (1987). Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. Journal of Bacteriology. 169(9). 4313–4319. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact